Jazz Pharmaceuticals (JAZZ)

Company Ticker Sector | Industry Quality PAR
Jazz Pharmaceuticals JAZZ Healthcare | Biotechnology 89 11.5%
Current Price (02/26) $168.04
CAPS Rating (Rate this stock on CAPS) Foolcaps 4
Expected Income Statement
Current Sales 2,279.8
Sales Growth Forecast 12.1%
Net Profit Margin 42.7%
Projected Shares Outstanding 65.44
EPS - Five year Forecast $26.36
Average P/E Ratio 11.0
Projected Average Price $289.97
Price Appreciation (Annualized) 11.5%
Annual Dividend Yield 0.0%
Projected Annual Return 11.5%
Quality
Financial Strength 83 20.7
EPS Stability 97 24.3
Industry Sales Growth Rate 17.0% 8.9
Industry Net Profit Margin 34.0% 15.7
Calculated Quality Rating 69.6
Fool CAPS

Total Players

287 Outperforms
67 Underperforms
 

All-Stars (60)

52 Outperforms (87%)
8 Underperforms
 
Fundamental Data Updated: 01/08/2021

MIPAR 5.7%  
Sweet Spot 10.7% - 15.7%  

Top In Biotechnology

Ticker Quality PAR
JAZZ 89 11.5%
REGN 75 19.9%
NVO 82 6.7%
CORT 49 16.8%
CBPO 63 9.6%

Top In Healthcare

Ticker Quality PAR
BMY 92 14.2%
RHHBY 87 13.4%
PKI 88 12.8%
MRK 89 12.5%
ANTM 87 12.4%